NASDAQ:ENLV
Enlivex Therapeutics Ltd.
- Stock
locale
Israel
market
STOCKSindustry
Biotechnologywebsite
www.enlivex.comipo date
Jul 31, 2014
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Z...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus